Vinals Guitart et al., 2024 - Google Patents
Engineered HMGB1 Construct with Tandem HMG B Domains that Promotes Tissue Regeneration without Potential for Deleterious Inflammation or ThrombosisVinals Guitart et al., 2024
View PDF- Document ID
- 18382707214860981701
- Author
- Vinals Guitart A
- Lee C
- Espirito Santo A
- Ruan J
- Redfield C
- Yue W
- Burgess-Brown N
- Fedorov O
- Nanchahal J
- Publication year
- Publication venue
- bioRxiv
External Links
Snippet
High Mobility Group Box 1 protein in its fully-reduced state (FR-HMGB1) binds to CXC Ligand 12 (CXCL12) and signals through CXC Receptor 4 (CXCR4) to transition stem and progenitor cells from the quiescent G0 state to GAlert. On exposure to tissue activating …
- 230000017423 tissue regeneration 0 title abstract description 10
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230137773A1 (en) | Ras inhibitory peptides and uses thereof | |
JP6486908B2 (en) | Designed ankyrin repeat protein that binds to hepatocyte growth factor | |
CN103459415B (en) | Designed repeat proteins that bind to serum albumin | |
JP2022068275A (en) | Fgf21 variants | |
KR102461666B1 (en) | Serum albumin binding fibronectin type III domain | |
KR20120125455A (en) | Intracelluar targeting bipodal peptide binder | |
JPWO2018117244A1 (en) | Peptides for the treatment of age-related macular degeneration | |
Vinals Guitart et al. | Engineered HMGB1 Construct with Tandem HMG B Domains that Promotes Tissue Regeneration without Potential for Deleterious Inflammation or Thrombosis | |
KR20220137876A (en) | Polypeptides related to HMGB1 useful for promoting tissue regeneration, compositions comprising same, and uses thereof | |
JP2019534858A (en) | Selective peptide inhibitor of FRIZZLED | |
JP6408555B2 (en) | Methods for identifying fusion proteins and bromodomain-inhibiting compounds | |
US20220275027A1 (en) | Atypical split inteins and uses thereof | |
US20210261603A1 (en) | Site-specific serine adp-ribosylated proteins and peptides and method for producing the same | |
JP7579844B2 (en) | Atypical split inteins and their uses | |
US20240101604A1 (en) | Selective mena binding peptides | |
WO2014068023A1 (en) | Dpp8 and dpp9 peptide inhibitors | |
US20230046828A1 (en) | Polypeptides Related to HMGB1 Useful for Promoting Tissue Regeneration, Compositions Comprising Same, and Uses Thereof | |
JP2024518125A (en) | HMGB1-related polypeptides useful for promoting tissue regeneration, compositions containing same and uses thereof | |
JP2024156675A (en) | Atypical split inteins and their uses | |
WO2020147508A1 (en) | Polypeptide for inhibiting tumor metastasis and bone tumors, and use thereof | |
US9145452B2 (en) | Application of fibrinogen-420 and its active domain | |
Tait | Isolation and characterization of recombinant U24, a membrane protein from Human Herpesvirus Type 6 | |
EA041577B1 (en) | TYPE III FIBRONECTIN BINDING DOMAIN | |
WO2014014816A2 (en) | Methods of treating glucose metabolism disorders |